Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Sells $53,840.83 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman sold 4,483 shares of Alignment Healthcare stock in a transaction dated Tuesday, October 29th. The stock was sold at an average price of $12.01, for a total value of $53,840.83. Following the completion of the transaction, the chief financial officer now owns 159,626 shares in the company, valued at approximately $1,917,108.26. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Robert Thomas Freeman also recently made the following trade(s):

• On Thursday, October 31st, Robert Thomas Freeman sold 36,197 shares of Alignment Healthcare stock. The stock was sold at an average price of $12.04, for a total value of $435,811.88.
• On Monday, October 14th, Robert Thomas Freeman sold 30,500 shares of Alignment Healthcare stock. The stock was sold at an average price of $11.50, for a total value of $350,750.00.
• On Tuesday, October 8th, Robert Thomas Freeman sold 39,320 shares of Alignment Healthcare stock. The stock was sold at an average price of $12.04, for a total value of $473,412.80.
• On Tuesday, October 1st, Robert Thomas Freeman sold 21,375 shares of Alignment Healthcare stock. The stock was sold at an average price of $10.66, for a total value of $227,857.50.
• On Friday, September 13th, Robert Thomas Freeman sold 14,500 shares of Alignment Healthcare stock. The stock was sold at an average price of $12.00, for a total value of $174,000.00.
• On Wednesday, September 11th, Robert Thomas Freeman sold 8,561 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.01, for a total value of $85,695.61.
• On Wednesday, September 4th, Robert Thomas Freeman sold 1,650 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.00, for a total value of $16,500.00.

Alignment Healthcare Stock Up 5.7 %

Shares of ALHC traded up $0.67 during mid-day trading on Thursday, reaching $12.40. The company had a trading volume of 2,410,721 shares, compared to its average volume of 1,029,118. The company has a debt-to-equity ratio of 1.70, a quick ratio of 1.61 and a current ratio of 1.61. The firm has a 50-day moving average price of $10.67 and a 200 day moving average price of $8.71. Alignment Healthcare, Inc. has a 52 week low of $4.46 and a 52 week high of $12.44. The company has a market capitalization of $2.37 billion, a price-to-earnings ratio of -15.12 and a beta of 1.47.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings results on Tuesday, October 29th. The company reported ($0.14) EPS for the quarter, hitting analysts’ consensus estimates of ($0.14). Alignment Healthcare had a negative return on equity of 101.10% and a negative net margin of 6.85%. The firm had revenue of $692.43 million for the quarter, compared to analysts’ expectations of $662.11 million. During the same period in the previous year, the firm posted ($0.19) EPS. The business’s revenue for the quarter was up 51.6% compared to the same quarter last year. On average, sell-side analysts forecast that Alignment Healthcare, Inc. will post -0.67 EPS for the current year.

Analyst Ratings Changes

A number of brokerages recently issued reports on ALHC. TD Cowen boosted their price target on Alignment Healthcare from $8.00 to $10.00 and gave the company a “buy” rating in a report on Tuesday, August 6th. Stifel Nicolaus boosted their price target on Alignment Healthcare from $9.00 to $12.00 and gave the company a “buy” rating in a report on Friday, July 26th. Robert W. Baird boosted their price target on Alignment Healthcare from $10.00 to $11.00 and gave the company an “outperform” rating in a report on Wednesday, August 14th. KeyCorp began coverage on Alignment Healthcare in a report on Friday, October 11th. They set a “sector weight” rating on the stock. Finally, Piper Sandler reiterated an “overweight” rating and set a $10.00 target price (up previously from $8.00) on shares of Alignment Healthcare in a report on Tuesday, August 6th. One research analyst has rated the stock with a sell rating, three have given a hold rating, six have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $10.33.

Institutional Trading of Alignment Healthcare

A number of hedge funds have recently made changes to their positions in ALHC. Deerfield Management Company L.P. Series C boosted its position in shares of Alignment Healthcare by 31.8% in the 2nd quarter. Deerfield Management Company L.P. Series C now owns 10,901,485 shares of the company’s stock worth $85,250,000 after purchasing an additional 2,630,788 shares in the last quarter. William Blair Investment Management LLC lifted its position in Alignment Healthcare by 94.4% in the 2nd quarter. William Blair Investment Management LLC now owns 3,104,681 shares of the company’s stock valued at $24,279,000 after acquiring an additional 1,507,759 shares in the last quarter. Hood River Capital Management LLC lifted its position in Alignment Healthcare by 49.6% in the 1st quarter. Hood River Capital Management LLC now owns 2,920,836 shares of the company’s stock valued at $14,487,000 after acquiring an additional 968,637 shares in the last quarter. Renaissance Technologies LLC lifted its position in Alignment Healthcare by 16.8% in the 2nd quarter. Renaissance Technologies LLC now owns 1,565,800 shares of the company’s stock valued at $12,245,000 after acquiring an additional 225,000 shares in the last quarter. Finally, AQR Capital Management LLC bought a new position in Alignment Healthcare in the 2nd quarter valued at approximately $1,512,000. 86.19% of the stock is owned by institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.